Sanara MedTech to Report First Quarter 2025 Financial Results on May 14, 2025

Core Viewpoint - Sanara MedTech Inc. is set to report its first quarter 2025 financial results on May 14, 2025, before U.S. markets open, indicating ongoing developments in its financial performance and business strategy [1]. Group 1: Financial Reporting - The company will host a conference call and webcast on May 14, 2025, at 8:00 a.m. Eastern Time to discuss the financial results for the quarter ended March 31, 2025, followed by a Q&A session [2]. - A telephonic replay of the conference call will be available until May 28, 2025, providing access to the discussion for those unable to attend live [2]. Group 2: Company Overview - Sanara MedTech Inc. focuses on developing and commercializing transformative technologies aimed at improving clinical outcomes and reducing healthcare costs in surgical, chronic wound, and skincare markets [4]. - The company markets and distributes a range of surgical, wound, and skincare products primarily in the North American advanced wound care and surgical tissue repair markets [4]. - Key products include CellerateRX Surgical Activated Collagen, FORTIFY TRG Tissue Repair Graft, and various advanced biologic products, indicating a diverse product portfolio [4]. - The company is actively seeking long-term strategic partnerships to enhance product offerings that improve outcomes at a lower overall cost [4].